Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 141

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 8
Chunk 141
---
2420252024Derivatives designated as cash flow hedging instruments:Foreign exchange forward contracts$858 $(5,713)$2,515 $(4,738)Interest rate swaps6,885 (14,030)(5,181)3,874 Total derivatives designated as cash flow hedging instruments$7,743 $(19,743)$(2,666)$(864)The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):Gains (Losses) Reclassified From Accumulated Other Comprehensive Income (Loss) into IncomeThree months ended September 30,Nine months ended September 30,Location of Gains (Losses)  Recognized in Net Loss2025202420252024Derivatives designated as cash flow hedging instruments:Foreign exchange forward contractsTotal revenues$(79)$740 $794 $2,073 Foreign exchange forward contractsCost of goods sold722 (843)(685)1,497 Interest rate swapsInterest expense2,915 7,020 9,987 22,273 Total derivatives designated as cash flow hedging instruments$3,558 $6,917 $10,096 $25,843 

As of September 30, 2025, we expect an estimated $2.1 million in deferred gains on the outstanding foreign exchange contracts and an estimated $4.1 million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.    

Note 10:  Fair Value Measurements

     Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:•Level 1:  quoted prices in active markets for identical assets or liabilities;•Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or•Level 3:  unobservable inputs that are supported by little or